FEATURED/ARCHIVES (09/05/24)
A Randomized Controlled Trial of a Patient-Centered Approach to Improve Screening for the Metabolic Side Effects of Antipsychotic Medications · April 2016
Articles (Manuscripts-Versions)
PubMed Central>Community Mental Health Journal
Effect of Clinical Decision Support on Cardiovascular Risk among Adults with Bipolar Disorder, Schizoaffective Disorder, or Schizophrenia: A Cluster Randomized Clinical Trial · March 2022
Articles
JAMA Network Open
Does Melatonin and Melatonin Agonists Improve the Metabolic Side Effects of Atypical Antipsychotics?: A Systematic Review and Meta-Analysis of Randomized Controlled Trials · August 2018
Articles
Clinical Psychopharmacology and Neuroscience
Acceptance and Commitment Therapy versus Social Support for Smoking Cessation for People with Schizophrenia: A Randomised Controlled Trial · September 2021
Articles
Journal of Clinical Medicine
A 6-Month, Randomized, Double-Blind, Placebo-Controlled Pilot Discontinuation Trial Following Response to Haloperidol Treatment of Psychosis and Agitation in Alzheimer’s Disease · December 2010
Articles (Manuscripts-Versions)
Europe PMC>International Journal of Geriatric Psychiatry
Measuring the Effectiveness of Psychoeducation on Adherence, Depression, Anxiety and Stress among Patients with Diagnosis of Schizophrenia: A Control Trial · June 2019
Articles
Current Psychology
Randomized Controlled Trial of Motivational Interviewing, Cognitive Behavior Therapy, and Family Intervention for Patients with Comorbid Schizophrenia and Substance Use Disorders · October 2001
Articles
American Journal of Psychiatry
A Pilot Nurse-Administered CBT Intervention for Insomnia in Patients with Schizophrenic Disorder: A Randomized Clinical Effectiveness Trial · September 2023
Articles
Journal of Clinical Medicine
Adjunctive Aripiprazole in Risperidone-Induced Hyperprolactinaemia: Double-Blind, Randomised, Placebo-Controlled Trial · December 2015
Articles
BJPsych Open
Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials · February 2022
Articles
Schizophrenia Bulletin
Adjunctive Risperidone Treatment in Post-Traumatic Stress Disorder: A Preliminary Controlled Trial of Effects on Comorbid Psychotic Symptoms · January 2003
Abstracts
International Clinical Psychopharmacology
Structured Lifestyle Education to Support Weight Loss for People with Schizophrenia, Schizoaffective Disorder and First Episode Psychosis: The STEPWISE RCT · November 2018
Publications (Books-Reports)
National Institute for Health Research
A Double-Blind, Placebo Controlled, Cross-Over Trial of Adjunctive Donepezil for Cognitive Impairment in Schizophrenia · June 2004
Articles
International Journal of Neuropsychopharmacology
Berberine Improves Negative Symptoms and Cognitive Function in Patients with Chronic Schizophrenia via Anti-Inflammatory Effect: A Randomized Clinical Trial · April 2023
Articles
Chinese Medicine
A Potential Role for Adjunctive Omega-3 Polyunsaturated Fatty Acids for Depression and Anxiety Symptoms in Recent Onset Psychosis: Results from a 16 Week Randomized Placebo-Controlled Trial for Participants Concurrently Treated with Risperidone · September 2018
Articles (Manuscripts-Versions)
PubMed Central>Schizophrenia Research
Novel Antipsychotics in the Treatment of Psychosis and Aggression Associated with Dementia: A Meta-Analysis of Randomized Controlled Clinical Trials · July 2000
Abstracts (Summaries)
University of York>International Psychogeriatrics
Effects of Omega-3 Fatty Acids on Metabolic Syndrome in Patients with Schizophrenia: A 12-Week Randomized Placebo-Controlled Trial · December 2018
Abstracts
Psychopharmacology
Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors · January 2016
Articles
Nutrients
Metabolic Side Effects in Persons with Schizophrenia during Mid- to Long-Term Treatment with Antipsychotics: A Network Meta-Analysis of Randomized Controlled Trials · January 2023
Articles
World Psychiatry
Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial · January 2017
Articles
NCBI>Iranian Journal of Medical Sciences